Related Experiment Video
Updated: Jun 22, 2026
36:30
Small Bowel Transplantation In Mice
Published on: August 20, 2007
[Small bowel transplantation: Report of a single case]
Erwin Buckel G1, Mario Ferrario B, Mario Uribe M
1Unidad de Gastroenterología, Clínica Las Condes. ebuckel@clinicalascondes.cl
Revista Medica De Chile
|June 23, 2009
Summary
The first small bowel transplant in Chile successfully restored a patient's health after short bowel syndrome. The patient recovered well, showing no graft rejection after 29 months.
Area of Science:
- Gastroenterology and Hepatology
- Transplantation Surgery
- Immunology
Background:
- Short bowel syndrome significantly impacts patient quality of life and necessitates specialized interventions.
- Small bowel transplantation offers a life-altering solution for end-stage intestinal failure, with established survival rates.
- The first small bowel transplantation in Chile was performed on a 36-year-old female patient.
Observation:
- The patient received a cadaveric small bowel graft.
- Immunosuppression involved a multi-drug regimen including alemtuzumab, tacrolimus, sirolimus, mycophenolate mofetil, and steroids.
- Post-transplant monitoring included serial endoscopies and biopsies over seven months.
Findings:
- The patient experienced late complications including drug-induced renal failure, opportunistic infections, and gastrointestinal bleeding.
- Despite complications, the patient achieved significant recovery, being ambulatory and on an oral diet.
- After 29 months of follow-up, there was no evidence of graft rejection.
Implications:
- This case demonstrates the feasibility and potential success of small bowel transplantation in a resource-limited setting.
- Effective management of immunosuppression and complications is crucial for long-term graft survival and patient well-being.
- Successful transplantation can significantly improve quality of life for patients with short bowel syndrome.
